• 
• http://www.neuropsychopharmacology.org
• Editor: James H. Meador-Woodruff, MD
• Volume 34: 13 issues per year
• ISSN: 0893-133X
• EISSN: 1740-634X
• Impact factor : 6.835*
• Impact ranking: 5/101 in Psychiatry; 18/219 in Neurosciences; 11/216 in Pharmacology & Pharmacy*
• Date Established: 1987
• Published on behalf of: American College of Neuropsychopharmacology

Aims and Scope:
Neuropsychopharmacology is an international scientific journal and the official publication of the American College of Neuropsychopharmacology (ACNP). This journal focuses on clinical and basic science contributions that advance our understanding of the brain and behaviour, especially as related to the molecular, cellular physiological and psychological properties of agents acting within the central nervous system and the identification of the new molecular targets for the development of the next generation of drugs.

Neuropsychopharmacology Reviews

www.neuropsychopharmacologyreviews.org

Considered the 13th issue of Neuropsychopharmacology and previously published as Generations of Progress, this reviews collection has been recently redesigned. The 2009 issue will cover barriers to drug discovery and development, complete with NPG-quality illustrations. Complimentary with any Neuropsychopharmacology subscription, it is also available for single issue purchase.

Readership:
Psychiatrists, neurologists, neurochemists, molecular biologists, pharmacologists and psychologists.

Online features and site license access:

• Online archive available back to 1994.
• A site license provides access to all content published during the supply period. Archive content is freely available after 12 months.
• Indexed in Medline (PubMed), BIOSIS, Chemical Abstracts, Current Contents Life Sciences, EMBASE, Elsevier BIOBASE, InPharma, PsycINFO Psychological Abstracts, SciSearch and Science Citation Index.

*2008 Journal Citation Report (Thomson Reuters, 2009)